White paperThe Enterprise Framework for Compliant, Scalable AI
Download now
AI deploymentGovernanceContinuous compliance

Intelligent Query Monitoring Helps Identify High- and Low-Performing Clinical Sites and Users

Explore ways to extract business insights from EDC metadata for query metrics, query causes, and query agents.

Client profile: Clinical-stage pharmaceutical company running multi-year clinical trials on a Veeva Electronic Data Capture (EDC) platform across multiple clinical sites.

Intelligent Query Monitoring Helps Identify High- and Low-Performing Clinical Sites and Users graphic

Executive takeaway

USDM delivered an AI-driven query analytics solution on Veeva EDC metadata in 28 days, cutting manual data review time by 50-60% and shortening trial timelines by 10-15%.

Review effort reduced

50-60%

Reduction in manual data review time through AI-driven query analytics, saving 200-500 hours per study.

Timeline accelerated

10-15%

Trial timeline decrease, equivalent to 2-6 months for multi-year studies.

Time to value

28 days

Full deployment of the SaaS solution, enabling rapid value realization and expansion to new use cases.

Before USDM

  • High query volumes and variable performance across clinical sites with no clear visibility into which sites or users underperformed.
  • Actionable insights locked inside Veeva EDC query data, trapped by siloed data and manual review processes.
  • Unanswered operational questions like time to database lock and the root causes of persistent queries.

After USDM

  • Clinical operations teams can readily identify high- and low-performing sites and users for targeted interventions.
  • Manual data review time reduced 50-60%, saving 200-500 hours per study, with faster database locks.
  • Trial timelines cut 10-15% (2-6 months) and a 15-25% acceleration in regulatory approval timelines.

The Challenge: Clinical Query Data Without Actionable Insight

Clinical trials are inherently complex, and ensuring data accuracy is a critical challenge exacerbated by high query volumes and variable performance across clinical sites. The customer, a clinical-stage pharmaceutical company, struggled to extract actionable business insights from the extensive clinical query data housed in their Veeva Electronic Data Capture (EDC) system. Key questions—such as the time required for database lock or the root causes of persistent queries—remained unanswered due to siloed data and manual processes.

Without a unified view, clinical operations teams had no reliable way to see which sites and users were driving query volume, how long resolution actually took, or where to focus remediation. The result was slow, manual data review and trial timelines that were harder to plan and protect.

The Approach: An AI-Powered, SaaS Query Monitoring Solution

To address these challenges, USDM developed an AI-powered, SaaS-based solution tailored to streamline and enhance clinical query management. Because the solution operated on regulated clinical data, it was designed with data integrity and 21 CFR Part 11 expectations in mind from the outset. The solution included:

Holistic Query Analytics

By integrating metadata from EDC and other potential sources, the solution provided:

  • Query Metrics: Operational insights, such as query turnaround times and volume trends, for continuous improvement.
  • Query Causes: Deep-dive analysis into root causes by event, form, and field, enabling optimized protocol and EDC designs.
  • Query Agents: Identify key contributors and highlight high-performing and underperforming site users and study team members.

Conversational AI Capabilities

Users could gain actionable insights by asking questions like:

  • "How many unresolved queries remain?"
  • "What impact does site performance variability have on query resolution times?"
  • "Which actions will expedite the resolution of critical queries?"

Predictive Analytics

Forecasting tools enabled:

  • Data cleaning workload predictions based on historical trends.
  • Accurate estimations of time required to lock databases, enhancing project planning and resource allocation.

Actionable Intelligence

Beyond insights, the solution prioritized actions to:

  • Optimize focus areas for Clinical Research Associates (CRAs) and site teams.
  • Address staffing or training deficiencies at underperforming sites.
  • Pinpoint and address inefficiencies in query resolution workflows.

Deploying AI against trial data this way depends on disciplined AI governance and compliance, so model outputs stay traceable, validated, and audit-ready throughout the study lifecycle.

The Results: Visibility, Efficiency, and Faster Timelines

By implementing USDM's AI-driven solution, the customer achieved transformative improvements:

  • Enhanced Performance Visibility: Clinical operations teams could easily identify high- and low-performing sites, enabling targeted interventions.
  • Improved Efficiency: Reducing manual data review time by 50-60%, saving 200-500 hours per study.
  • Accelerated Timelines: Trial timelines decreased by 10-15%, equating to 2-6 months for multi-year studies.
  • Optimized Data Cleaning: The customer could predict and manage data cleaning workloads more effectively, leading to faster database locks.
  • Increased Regulatory Speed: The improvements in data accuracy and process efficiency contributed to a 15-25% acceleration in regulatory approval timelines.

Time to Value

USDM's solution demonstrated rapid implementation, achieving full deployment within 28 days. This ensured the customer could quickly realize value and build on their success by expanding use cases, such as missing page reporting and user-level performance analytics. Sustaining these gains over time is where a continuous compliance mindset keeps validated analytics performing reliably as protocols, sites, and study data evolve.

USDM helps life sciences organizations maintain, optimize, and continuously improve their Veeva Vault platforms through expert advisory services, managed application support, and Cloud Assurance — turning Vault from a system of record into a platform that accelerates business operations. With 250+ Veeva projects and 25 years of regulatory expertise across 900+ organizations, USDM delivers post-implementation governance, compliance readiness, automated testing, and operational support that reduces technical debt and drives measurable gains like 20-40% faster document approvals and up to 50-80% reduction in security profiles.

The takeaway: intelligent query monitoring turned trapped EDC metadata into a clear view of site and user performance—cutting manual review by 50-60%, saving 200-500 hours per study, and accelerating trial and regulatory timelines, all within 28 days of deployment.

Additional Veeva Resources

Datasheet: Veeva Advisory Datasheet

White Paper: Is Your Veeva Vault Operating Model Ready for AI?

Veeva + USDM Partnership Overview

Turn EDC metadata into clinical insight

Bring AI-driven query monitoring to your clinical trials

USDM helps life sciences organizations extract validated, compliant insight from Veeva EDC and other clinical systems—accelerating database lock and regulatory timelines while keeping data integrity intact. Let's map what intelligent query monitoring could do for your studies.

Talk to a clinical data expert

Go deeper

Related guidance

Blogs, webinars, and white papers on the capabilities behind this outcome.

Blog

Evaluating Google Agentspace for Life Sciences

A practical 10-factor framework for life sciences teams evaluating Google Agentspace—covering GxP compliance, data security, auditability, multi-agent governance, and ROI for confident, validated AI adoption.

Read
Blog

Workforce Optimization: Maximizing Employee Efficiency and Productivity

Workforce optimization puts the right people on the right tasks at the right time. Explore data-driven strategies and delivery models that boost efficiency, productivity, and compliance in life sciences.

Read
White Paper

Anticipating Regulatory Compliance for Artificial Intelligence in Life Sciences

A practical white paper for Quality, Regulatory, IT, and Data leaders on governing, validating, and monitoring AI in GxP workflows ahead of FDA and global regulatory expectations.

Read
Blog

Achieving Unprecedented Value from your Veeva Investments

Unlock the full value of your Veeva investment with USDM Life Sciences. Break down data silos, overcome integration barriers, and tame platform complexity with tailored, GxP compliance-ready solutions.

Read
Blog

Boost Efficiency and Anticipate Trends with AI-Driven Predictive Analytics in Life Sciences

AI-driven predictive analytics helps life sciences organizations accelerate drug discovery, sharpen demand forecasting, and reduce manufacturing downtime. Explore the use cases, best practices, and governance steps for putting predictive AI to work.

Read
Blog

Claude Cowork for Life Sciences: From Chatbot to Governed Work Partner

USDM explains how life sciences teams can evaluate Claude Cowork as a governed work partner, not an unmanaged chatbot, with clear intended use, human review, and audit-ready controls.

Read

Start here

Put AI to work in life sciences — with the right guardrails underneath.

Start with a structured AI Readiness Assessment: fixed-fee, executive-ready, and built to surface the highest-value workflows first.

Start here

Talk to USDM

Tell us what workflow or outcome you want to improve and we'll map the right AI, governance, and delivery path.

By submitting this form, you agree to USDM’s Privacy Policy and consent to receive communications from USDM. You can unsubscribe at any time using the link in our emails.